What is Astrana Health Inc (ASTH) stock price today?

Astrana Health Inc (ASTH) currently trades at $35.02 per share. The stock has a market capitalization of $1.95B and a P/E ratio of 76.12x.

Is ASTH stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Astrana Health Inc has a Smart Value Score of 44/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the ASTH stock price target for 2026?

WallStSmart's 12-month price target for Astrana Health Inc is $11.04.

What is Astrana Health Inc's revenue and earnings?

Astrana Health Inc has trailing twelve-month (TTM) revenue of $3.18B with profit margins of 0.71%. Earnings per share (EPS) is $0.46.

ASTH

Astrana Health Inc

NASDAQ: ASTH · HEALTHCARE · MEDICAL CARE FACILITIES

$35.02

+0.36% today

Updated 2026-04-29

Market cap

$1.95B

P/E ratio

76.12

P/S ratio

0.61x

EPS (TTM)

$0.46

Dividend yield

—

52W range

$18 – $35

Volume

0.5M

Market cap

$1.95B

P/E ratio

76.12

P/S ratio

0.61x

EPS (TTM)

$0.46

Dividend yield

—

52W range

$18 – $35

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

7.3

Growth

B+

5.0

Quality

C+

4.5

Profitability

4.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$36.89

+5.35%

12-Month target

$11.04

-68.47%

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy8 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 42.90% QoQ

Risks

- Thin margins at 0.71%

- Negative free cash flow $-2.89M

- P/E 76.12x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.14B	$1.39B	$2.03B	$3.18B	$3.18B
Net income	$45.17M	$60.72M	$43.15M	$22.49M	$6.00M
EPS	—	—	—	—	$0.46
Free cash flow	$59.19M	$39.70M	$44.17M	$104.49M	$-2.89M
Profit margin	3.95%	4.38%	2.12%	0.71%	0.71%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ASTH	$1.95B	44	7.3	4.5	4.0	5.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Astrana Health Inc trades at $35.02. representing a P/E of 76.12x trailing earnings. Our Smart Value Score of 44/100 indicates the stock is fair. TTM revenue stands at $3.18B. with profit margins at 0.71%.

Frequently asked questions

What is Astrana Health Inc's stock price?

Astrana Health Inc (ASTH) trades at $35.02.

Is Astrana Health Inc overvalued?

Smart Value Score 44/100 (Grade D, Sell).

What is the price target of Astrana Health Inc (ASTH)?

The analyst target price is $36.89, representing +5.4% upside from the current price of $35.02.

What is Astrana Health Inc's revenue?

TTM revenue is $3.18B.

Company info

SectorHEALTHCARE

IndustryMEDICAL CARE FACILITIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.61x

ROE4.49%

Beta0.77

50D MA$26.03

200D MA$26.29

Shares out0.06B

Float0.04B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ASTH vs LLY →ASTH vs JNJ →ASTH vs ABBV →Stock screener →